Companies category powered by

IMER Cyprus: CAR-T cancer treatment may be administered out-patient

IMER medical services has announced that the Israeli CAR-T cancer treatment could be administered out-patient – which would be a first in world.

The therapy was developed at Hadassah University Hospital to treat Multiple Myeloma, AL Amyloidosis and other BCMA-positive malignancies.

Prof Polina Stepensky, Dr Shlomit Kfir-Erenfeld and Dr Nathalie Asherie of Hadassah’s Bone Marrow Transplantation Department, in collaboration with Prof Cyrille J. Cohen of Bar-Ilan University, developed the CAR-T treatment for myeloma.

Chimeric antigen receptor T-cell therapy is a treatment in which a patient’s T-cells are altered in a lab to attack cancer cells. Myeloma, AL amyloidosis and BCMA-positive malignancies are all types of blood cancers. The first two are generally found in the bone marrow.

iMER (International Medical Evaluation and Referrals) is a Worldwide Health Services Provider and the exclusive representative of Hadassah University Hospital in Greece and Cyprus since March 2007, with offices in Cyprus (Nicosia and Limassol) and Israel (in Hadassah hospital).

Read More

Demetris Skourides: RIF is the driving force behind Cyprus’ journey to becoming a major tech hub
Cyprus economic growth for 2023 estimated at 2.5%
The first Women Leaders' Forum is happening soon
Pancyprian essay contest for World DNA Day 2024
KPMG in Cyprus sponsors part of NICU renovation at Makarios Hospital
Century Travel opens 2025 bookings with Marella Cruises from Limassol Port
CARDET showcases advanced digital learning systems at CF SEDSS workshop
Eleni Kaloyirou: Our priority for 2024 is to stabilise and improve connectivity (video)
TIMS opening at Nicosia Mall and MyMall
Wizz Air awarded for investment in Firefly’s sustainable aviation fuel technology